Abstract: A steam turbine valve abnormality monitoring system according to an embodiment includes a detection unit detecting the state of a steam turbine valve or a steam turbine valve drive device, a determination unit, and an abnormality processing unit. Based on the detected result of the detection unit, the determination unit determines whether or not an abnormality has occurred in the opening degree control of the steam turbine valve. The abnormality processing unit issues an alarm or issues a turbine stop command when the determination unit determines that an abnormality has occurred in the opening degree control of the steam turbine valve.

Abstract: A steam turbine valve abnormality monitoring system according to an embodiment includes a detection unit detecting the state of a steam turbine valve or a steam turbine valve drive device, a determination unit, and an abnormality processing unit. Based on the detected result of the detection unit, the determination unit determines whether or not an abnormality has occurred in the opening degree control of the steam turbine valve. The abnormality processing unit issues an alarm or issues a turbine stop command when the determination unit determines that an abnormality has occurred in the opening degree control of the steam turbine valve.

Abstract: The present invention aims at providing a novel polypeptide, a receptor, a DNA thereof, and the like. Specifically, the present invention provides a polypeptide having a binding ability to the protein represented by SEQ ID NO: 1 or SEQ ID NO: 3, or its amide, its ester or its salt, a polynucleotide encoding the polypeptide, an antisense polynucleotide or an antibody to the polypeptide, a screening of agent for prevention and/or treatment of cancer, obesity, etc., which comprises using the above, and the like. The polypeptide, receptor, polynucleotide, antisense polynucleotide, antibody and the like are useful for an agent of prevention and/or treatment of cancer, obesity and the like. Further, they are useful for a screening of an agent for prevention and/or treatment of cancer, obesity and the like.

Abstract: A protein having an amino acid sequence which is the same or substantially the same as an amino acid sequence represented by SEQ ID NO:1, SEQ ID:8, SEQ ID NO:11 or SEQ ID NO:15 is useful as, for example, a diagnostic marker for digestive diseases, immune diseases associating thymic disorders, pancreatic diseases, diabetes, genital diseases, central nerve system diseases, circulatory diseases, muscular diseases, cancer, etc. A compound promoting or inhibiting the activity of this protein which is obtained by a screening method with the use of the protein is usable as, for example, a preventive or a remedy for the above diseases.

Abstract: The present invention aims at providing a novel polypeptide, a receptor, a DNA thereof, and the like. Specifically, the present invention provides a polypeptide having a binding ability to the protein represented by SEQ ID NO: 1 or SEQ ID NO: 3, or its amide, its ester or its salt, a polynucleotide encoding the polypeptide, an antisense polynucleotide or an antibody to the polypeptide, a screening of agent for prevention and/or treatment of cancer, obesity, etc., which comprises using the above, and the like. The polypeptide, receptor, polynucleotide, antisense polynucleotide, antibody and the like are useful for an agent of prevention and/or treatment of cancer, obesity and the like. Further, they are useful for a screening of an agent for prevention and/or treatment of cancer, obesity and the like.

Abstract: A (2R,3S)-3-hydroxy-2-methylbutyrate is efficiently and selectively produced by microbial asymmetric reduction of a 2-methyl-3-oxobutyrate with a bacterial strain or its processed material.

Abstract: A (1R,2S)-2-hydroxycycloalkanecarboxylic acid ester is efficiently and selectively produced by microbial asymmetric reduction of a 2-oxocycloalkanecarboxylic acid ester with a bacterial strain or its processed material.